Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.
about
Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illnessThe molecular genetics and cellular mechanisms underlying pulmonary arterial hypertensionDrug treatment of pulmonary hypertension in childrenPharmacotherapy for pulmonary hypertensionRecent progress in understanding pediatric pulmonary hypertensionTreprostinil for the treatment of pulmonary arterial hypertensionPulmonary Hypertension in Children.Prostacyclin in the intensive care setting.Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.Non-congenital heart disease associated pediatric pulmonary arterial hypertensionPulmonary hypertension in bronchopulmonary dysplasiaAdvances in pediatric pulmonary arterial hypertension.Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.Treatment of pulmonary hypertensionAcute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.Current challenges in pediatric pulmonary hypertension.Advances in therapies for pediatric pulmonary arterial hypertension.Pharmacokinetic evaluation of continuous intravenous epoprostenol.Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations.Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.A review of therapeutic agents for the management of pulmonary arterial hypertension.Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.Beyond the evidence: treating pulmonary hypertension in the intensive care unit.Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapy.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.
P2860
Q26863639-0A147722-E85F-40DF-9C9A-4B2A356DB5D1Q26992278-60992647-D6C0-4AA7-ABE5-C6DCD12F5F81Q26996078-8545D8A0-6148-4628-AD79-C2F2B526D640Q27022763-8CC73DF6-0FB1-44FD-AA02-7C9B27B9C2E4Q27691453-1EB14ECE-9BBE-4EDB-833B-A2E85639E5F0Q28281899-6FDE7BCF-C472-4414-826D-F3E229FD7394Q30248871-2866E113-4913-41F7-8DB2-00C15E784B5EQ35050464-36C341B0-7C71-4E76-AF1C-4F7EB6BA31D5Q35051737-3A40E8B7-DC74-48AC-ACB1-16D6558C39C4Q35165691-9B9D1CB4-0C33-4852-85E0-52D916D4263EQ35731631-687D1491-E262-44BA-8DEE-0F83BF93CB7FQ35869437-58BA21CF-644D-4C25-BCEA-7E4028A75A8AQ36399577-392BDCCA-6E2F-4506-AEDA-3BC26890B4D1Q36481525-246DACEE-9608-4933-AB27-ED5DAB84B257Q36577681-BD2AF2BC-7D83-4609-B598-C01D169CC830Q36718346-384FC263-A430-4959-8E67-46FA20C2D10CQ36763080-E592B5D4-1DE4-4DFC-806B-E324997AF015Q36777766-E6265923-A341-4AD8-81B8-FA8A86D27E03Q37540613-C4840F73-25DE-4B0E-B2CF-C9B18BFD389DQ37755020-DA188A81-CB4B-49DA-A542-603F50691411Q37809538-A1329443-4541-432F-8E4D-465EE8700289Q38066529-DF773E9D-0470-47C7-8B7D-757BC47718D2Q38817507-86CB4FFB-ACF5-47F8-ABA8-2BC65E70A875Q38946618-B40A6D8E-26A0-4A64-9371-661D16F5CBE7Q40243009-A7624963-8A8E-448E-B81B-4393635CDDCEQ42145097-11526884-FD4B-4E4E-802F-E1170D5154F2Q45363251-9102B7C7-0263-46C2-A25E-5ED219B42288Q46673537-B230500F-D0E5-4F5F-BF92-2A8AA4ED93C2Q50139964-9726F4CB-8C37-4F93-AB39-1D7AB26E76C2Q55001904-721347E1-A4D5-49C2-B759-9979B117E1DB
P2860
Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Guidelines for the prevention ...... lmonary arterial hypertension.
@en
Guidelines for the prevention ...... lmonary arterial hypertension.
@nl
type
label
Guidelines for the prevention ...... lmonary arterial hypertension.
@en
Guidelines for the prevention ...... lmonary arterial hypertension.
@nl
prefLabel
Guidelines for the prevention ...... lmonary arterial hypertension.
@en
Guidelines for the prevention ...... lmonary arterial hypertension.
@nl
P2093
P2860
P1476
Guidelines for the prevention ...... lmonary arterial hypertension.
@en
P2093
Scientific Leadership Council of the Pulmonary Hypertension Association
P2860
P356
10.1111/J.1742-1241.2008.01811.X
P577
2008-07-01T00:00:00Z